By expenditures
| Name | Title | Type |
|---|---|---|
| Tom Hodnefield | Partner | Auditee |
| Rob Novak | Chief Financial Officer | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 374340 | 2025 | 2025-12-12 | REDPATH AND COMPANY LLC | $3.12M |
| 325145 | 2024 | 2024-10-18 | Redpath and Company LLC | $4.61M |
| 8395 | 2023 | 2023-12-26 | Redpath and Company LLC | $3.73M |
| 18215 | 2022 | 2022-10-19 | Redpath and Company | $2.87M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 325145 | 2024 | 2024-10-18 | 1079584 | 2024-002 | Significant Deficiency | - | E |
| 325145 | 2024 | 2024-10-18 | 1079583 | 2024-002 | Significant Deficiency | - | E |
| 325145 | 2024 | 2024-10-18 | 1079582 | 2024-002 | Significant Deficiency | - | E |
| 325145 | 2024 | 2024-10-18 | 1079581 | 2024-002 | Significant Deficiency | - | E |
| 325145 | 2024 | 2024-10-18 | 1079580 | 2024-002 | Significant Deficiency | - | E |
| 325145 | 2024 | 2024-10-18 | 1079579 | 2024-002 | Significant Deficiency | - | E |
| 325145 | 2024 | 2024-10-18 | 1079578 | 2024-002 | Significant Deficiency | - | E |
| 325145 | 2024 | 2024-10-18 | 1079577 | 2024-002 | Significant Deficiency | - | E |
| 325145 | 2024 | 2024-10-18 | 1079576 | 2024-002 | Significant Deficiency | - | E |
| 325145 | 2024 | 2024-10-18 | 1079575 | 2024-002 | Significant Deficiency | - | E |
| 325145 | 2024 | 2024-10-18 | 503142 | 2024-002 | Significant Deficiency | - | E |
| 325145 | 2024 | 2024-10-18 | 503141 | 2024-002 | Significant Deficiency | - | E |
| 325145 | 2024 | 2024-10-18 | 503140 | 2024-002 | Significant Deficiency | - | E |
| 325145 | 2024 | 2024-10-18 | 503139 | 2024-002 | Significant Deficiency | - | E |
| 325145 | 2024 | 2024-10-18 | 503138 | 2024-002 | Significant Deficiency | - | E |
| 325145 | 2024 | 2024-10-18 | 503137 | 2024-002 | Significant Deficiency | - | E |
| 325145 | 2024 | 2024-10-18 | 503136 | 2024-002 | Significant Deficiency | - | E |
| 325145 | 2024 | 2024-10-18 | 503135 | 2024-002 | Significant Deficiency | - | E |
| 325145 | 2024 | 2024-10-18 | 503134 | 2024-002 | Significant Deficiency | - | E |
| 325145 | 2024 | 2024-10-18 | 503133 | 2024-002 | Significant Deficiency | - | E |